QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities

Malaria is a life-threatening infectious disease caused by parasites of the genus , affecting more than 200 million people worldwide every year and leading to about a half million deaths. Malaria parasites of humans have evolved resistance to all current antimalarial drugs, urging for the discovery...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2018-03, Vol.9, p.146-146
Main Authors: Lima, Marilia N N, Melo-Filho, Cleber C, Cassiano, Gustavo C, Neves, Bruno J, Alves, Vinicius M, Braga, Rodolpho C, Cravo, Pedro V L, Muratov, Eugene N, Calit, Juliana, Bargieri, Daniel Y, Costa, Fabio T M, Andrade, Carolina H
Format: Article
Language:English
Subjects:
dUTPase
malaria
Pharmacology
Plasmodium falciparum
QSAR
transmission blocker
virtual screening
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Malaria is a life-threatening infectious disease caused by parasites of the genus , affecting more than 200 million people worldwide every year and leading to about a half million deaths. Malaria parasites of humans have evolved resistance to all current antimalarial drugs, urging for the discovery of new effective compounds. Given that the inhibition of deoxyuridine triphosphatase of ( dUTPase) induces wrong insertions in plasmodial DNA and consequently leading the parasite to death, this enzyme is considered an attractive antimalarial drug target. Using a combi-QSAR (quantitative structure-activity relationship) approach followed by virtual screening and experimental evaluation, we report herein the discovery of novel chemical scaffolds with potency against asexual blood stages of both multidrug-resistant and sensitive strains and against sporogonic development of . We developed 2D- and 3D-QSAR models using a series of nucleosides reported in the literature as dUTPase inhibitors. The best models were combined in a consensus approach and used for virtual screening of the ChemBridge database, leading to the identification of five new virtual dUTPase inhibitors. Further testing on multidrug-resistant (W2) and sensitive (3D7) parasites showed that compounds LabMol-144 and LabMol-146 demonstrated fair activity against both strains and presented good selectivity versus mammalian cells. In addition, LabMol-144 showed good inhibition of ookinete formation, demonstrating that hit-to-lead optimization based on this compound may also lead to new antimalarials with transmission blocking activity.
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2018.00146